Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,286
Closed -$338K 125
2022
Q4
$338K Sell
1,286
-79
-6% -$21.2K 0.22% 74
2022
Q3
$308K Buy
1,365
+160
+13% +$38.8K 0.22% 70
2022
Q2
$293K Sell
1,205
-77
-6% -$18.9K 0.22% 75
2022
Q1
$310K Buy
1,282
+122
+11% +$28K 0.21% 78
2021
Q4
$261K Sell
1,160
-30
-3% -$6.33K 0.18% 90
2021
Q3
$253K Buy
+1,190
New +$274K 0.22% 85

Other funds holding AMGN

Blue Barn Wealth's AMGN Position: Q1 2023 in Review

Blue Barn Wealth sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,286 shares — an estimated $338K sold.

Blue Barn Wealth first reported a position in AMGN in Q3 2021 and held it in 6 quarters. The position peaked at $338K in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Blue Barn Wealth reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Blue Barn Wealth sold 1,286 Amgen shares in Q1 2023, an estimated $338K.
  • Blue Barn Wealth first reported a position in Amgen in Q3 2021 and held it in 6 quarters.
  • Blue Barn Wealth's Amgen position peaked at $338K in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Blue Barn Wealth's 13F filing for Q1 2023, filed 11 May 2023.